Advertisement

Five members rotate off the NCI Board of Scientific Advisors

Share on facebook
Share on twitter
Share on linkedin
Share on email
Share on print

Five members are rotating off THE NCI BOARD OF SCIENTIFIC ADVISORS. They are: Todd Golub, (chair), chief scientific officer at the Broad Institute of Massachusetts Institute of Technology and Harvard University.Curt Civin, director of the Center for Stem Cell Biology and a regenerative medicine professor of pediatrics and physiology associate dean for research at the...

To access this subscriber-only content please log in or subscribe.

If your institution has a site license, log in with IP-login or register for a sponsored account.*
*Not all site licenses are enrolled in sponsored accounts.

Login Subscribe
Advertisement
Advertisement

YOU MAY BE INTERESTED IN

In an effort to target the right patients, genetic screening is becoming more common in clinical trials. But incorporating it can be complex and add a significant burden for both patients and clinical trial sites. Genetic counseling can streamline that process and help drug and gene therapy developers expedite the recruitment of genetically-eligible participants for their trials and use genetic testing results to accelerate the speed and success of clinical trials.
Advertisement
Advertisement